Invests in
Stages:
Sectors:
Locations:
Min Investment:
$500,000.00Max Investment:
$50,000,000.00Target Investment:
$25,000,000.00
Education
- HU
- DU
Lists including Carmichael
Investments
Molten Industries
Total Funding: $25M
Planted Solar
Total Funding: $20M
Reactive Technologies
Total Funding: $47M
Rize
Total Funding: $31M
Windfall Bio
Total Funding: $37M
Mission Zero
Total Funding: $33M
Lilac Solutions
Total Funding: $320M
Heart Aerospace
Total Funding: $140M
Albedo
Total Funding: $100M
Fourth Power
Total Funding: $19M
Work Experience
2016
Founder and Managing Partner
2016
Material Impact transforms materials into companies that make an impact.
Member
2017
2014
Director
2014
2013
Chairman Of The Board
2013
2008
Co-founder and Chairman of the Board
2008
Co-founded and serve as Chairman of the Board. Sourced the technology out of the University of Illinois. Incubated the platform at the offices at North Bridge. Recruited and hired the executive team.
2008
Chairman Of The Board
2008
Served as Chairman of the Board since inception. Scouted the technology out of MIT and worked closely with the CEO to recruit and hire the managing team. Developed the strategy to collaborate with large corporates.
2007
Co-Founder and Chairman of the Board
2007
Established a creative hybrid non-profit and for-profit business model in conjunction with Harvard University. Recruited the business and technical team. Crafted the strategy for commercial launch of diagnostic devices including a close collaboration with the Gates Foundation, the organization’s flagship funder.
2005
Co-Founder and Lead Director
2005
Co-Founded and recruited the initial thirty member team, including the CEO, CTO, VP of Business Development, and VP of Engineering. Raised the initial $20 million from top-tier venture capital firms and guided the company on its initial commercial applications in trauma, blood vessel and joint repair.
2009 - 2018
Lead Director
2009 - 2018
Co-founded and served as Chairman of the Board from the company's inception. Worked closely with the CEO to scout the technology platform, recruit and hire the managing team and develop the strategy for collaboration with large companies.
2005 - 2018
Co-Founder and Chairman of the Board
2005 - 2018
Hired key scientists and recruited a stellar executive team from the executive ranks at Genzyme and Boston Scientific. Built the investor syndicate including Medtronic, a critical strategic company that sits on the board.